Cargando…

Inhibition of Syndecan-4 by therapeutic antibodies reduces TNFα dependent joint destruction in mice

Detalles Bibliográficos
Autores principales:	Stratis, Athanasios, Neugebauer, Katja, Frohling, Mareike, Paruzel, Peter, Dankbar, Berno, Wemeyer, Corinna, Cromme, Christoph, Godmann, Lars, Bertrand, Jessica, Korb, Adelheide, Echtermeyer, Frank, Kollias, George, Pap, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332460/ http://dx.doi.org/10.1186/ar3665

Ejemplares similares

Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis
por: Wäldele, Stefan, et al.
Publicado: (2015)

Smad-dependent mechanisms of inflammatory bone destruction
por: Fennen, Michelle, et al.
Publicado: (2016)

Matrix remodeling during enchondral ossification and aggrecan cleavage in osteoarthritic cartilage depends on syndecan-4
por: Echtermeyer, Frank, et al.
Publicado: (2007)

Deletion of activin A in mesenchymal but not myeloid cells ameliorates disease severity in experimental arthritis
por: Waltereit-Kracke, Vanessa, et al.
Publicado: (2022)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis
por: Fennen, Michelle, et al.
Publicado: (2021)

Cell Surface-Bound TIMP3 Induces Apoptosis in Mesenchymal Cal78 Cells through Ligand-Independent Activation of Death Receptor Signaling and Blockade of Survival Pathways
por: Koers-Wunrau, Christina, et al.
Publicado: (2013)

The bacterial effector protein YopM reduces rheumatoid arthritis (RA) outcome by inhibiting inflammation and bone destruction
por: Bertrand, J, et al.
Publicado: (2012)

Syndecan-1 as a Regulator of Chemokine Function
por: Götte, Martin, et al.
Publicado: (2003)

Osteoclasts are essential for TNF-mediated joint destruction
por: Redlich, KR, et al.
Publicado: (2002)

Lasp1 regulates adherens junction dynamics and fibroblast transformation in destructive arthritis
por: Beckmann, Denise, et al.
Publicado: (2021)

Isolated and combined inhibition of TNF-, IL-1 and RANKL-pathways in TNF-induced arthritis: effects on synovial inflammation, bone erosion and cartilage destruction
por: Zwerina, J, et al.
Publicado: (2003)

High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression
por: Qing, Qing, et al.
Publicado: (2015)

The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts
por: Diller, Magnus, et al.
Publicado: (2019)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
por: Goutebroze, Laurence, et al.
Publicado: (2003)

A Critical Role of the p75 Tumor Necrosis Factor Receptor (p75TNF-R) in Organ Inflammation Independent of TNF, Lymphotoxin α, or the p55TNF-R
por: Douni, Eleni, et al.
Publicado: (1998)

Salivary TNF-alpha: A potential marker of periodontal destruction
por: Singh, Pritma, et al.
Publicado: (2014)

MAPK signalling in rheumatoid joint destruction: can we unravel the puzzle?
por: Meyer, Lars-Henrik, et al.
Publicado: (2005)

Gene therapy in rheumatoid arthritis: how to target joint destruction?
por: Pap, Thomas, et al.
Publicado: (1999)

Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level: Implications for Pathogenesis and Therapy of Autoimmune Demyelination
por: Kassiotis, George, et al.
Publicado: (2001)

Syndecan-Regulated Receptor Signaling
por: Rapraeger, Alan C.
Publicado: (2000)

Syndecan-3 gets the message
por: Leslie, Mitch
Publicado: (2011)

The Cardiac Syndecan-2 Interactome
por: Mathiesen, Sabrina Bech, et al.
Publicado: (2020)

Syndecan-3 in Inflammation and Angiogenesis
por: Arokiasamy, Samantha, et al.
Publicado: (2020)

Syndecans in Inflammation at a Glance
por: Gopal, Sandeep
Publicado: (2020)

Syndecan-1 in Liver Diseases
por: Regős, Eszter, et al.
Publicado: (2019)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2
por: Péterfia, Bálint, et al.
Publicado: (2012)

Extended disorder at the cell surface: The conformational landscape of the ectodomains of syndecans
por: Gondelaud, Frank, et al.
Publicado: (2021)

Suppressing Syndecan-1 Shedding Ameliorates Intestinal Epithelial Inflammation through Inhibiting NF-κB Pathway and TNF-α
por: Zhang, Yan, et al.
Publicado: (2016)

Synovial fibroblasts display an uncontrolled inflammatory and tissue destructive response to TNF-α
por: Kalliolias, George D, et al.
Publicado: (2012)

Transfer of protease inhibitors to inhibit cartilage destruction
por: van der Laan, WH, et al.
Publicado: (2001)

Binding of Y-P30 to Syndecan 2/3 Regulates the Nuclear Localization of CASK
por: Landgraf, Peter, et al.
Publicado: (2014)

The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle
por: Hallberg, Gunilla, et al.
Publicado: (2010)

Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols
por: Douni, Eleni, et al.
Publicado: (2004)

Membrane-Bound TNF Induces Protective Immune Responses to M. bovis BCG Infection: Regulation of memTNF and TNF Receptors Comparing Two memTNF Molecules
por: Olleros, Maria L., et al.
Publicado: (2012)

Induced expression of syndecan in healing wounds
Publicado: (1991)

The expression of syndecan-1 in psoriatic epidermis
por: Tomas, Davor, et al.
Publicado: (2008)

Syndecans in tumor cell adhesion and signaling
por: Beauvais, DeannaLee M, et al.
Publicado: (2004)

A syndecan-based tumor stopper
por: Maxmen, Amy
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_euppe2brpclkad28s2aov4fis4